![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0767 | -22.4926686217 | 0.341 | 0.378 | 0.2514 | 1122852 | 0.34782395 | CS |
4 | -0.203 | -43.441044297 | 0.4673 | 0.6196 | 0.2514 | 615853 | 0.39950686 | CS |
12 | -0.3456 | -56.6650270536 | 0.6099 | 0.9374 | 0.2514 | 429280 | 0.49809893 | CS |
26 | -0.3837 | -59.212962963 | 0.648 | 1.1099 | 0.2514 | 342891 | 0.65216139 | CS |
52 | -0.6057 | -69.6206896552 | 0.87 | 1.87 | 0.2514 | 177594 | 0.67513362 | CS |
156 | -4.2557 | -94.1526548673 | 4.52 | 4.6 | 0.2514 | 75562 | 1.10375179 | CS |
260 | -14.6957 | -98.2332887701 | 14.96 | 19.56 | 0.2514 | 347187 | 10.04587774 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions